Abstract
The quinolone analog SQ-4004 has been identified as a potentially excellent anti-ischemic agent, which exhibited highly potent efficacy in reducing infarct volume size in vivo rat MCAO model (32.1% at 0.01 mg/kg) and potent cardioprotective effect at myocardial infarction in vivo model (26.6% at 0.01 mg/kg) while it exhibited highly reduced anti-bacterial activity. The mechanistic study revealed that the anti-ischemic activity might exert via an anti-apoptotic pathway, which implies its therapeutic uses against the ischemic cell injuries including ischemic stroke and ischemic heart disease.
Original language | English |
---|---|
Pages (from-to) | 6517-6526 |
Number of pages | 10 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 15 |
Issue number | 20 |
DOIs | |
State | Published - 15 Oct 2007 |
Externally published | Yes |
Bibliographical note
Funding Information:This work was supported by a grant from the Seoul R& BD Program and the Research Institute of Medical Science, Catholic University of Daegu.
Keywords
- Anti-apoptotic activity
- Anti-ischemic agents
- MCAO
- MI
- Quinolone analog
- Structure-activity relationship